What is the difference in treatment between infantile colic and Period of PURPLE (Persistent Unexplained Crying, Random, Resistant to soothing, Peaks around 6 weeks, and Ends by 3-4 months) Crying?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Infantile Colic vs. PURPLE Crying: Key Differences in Treatment

Infantile colic and PURPLE crying are essentially the same phenomenon described through different frameworks—both represent normal developmental crying patterns that require parental reassurance and support rather than distinct medical treatments. 1, 2

Understanding the Terminology

PURPLE crying is not a separate diagnosis from infantile colic; it is an educational framework developed to help parents understand normal infant crying patterns. 1 The acronym describes characteristics that overlap completely with colic:

  • Peak of crying around 6 weeks
  • Unpredictable episodes
  • Resistant to soothing
  • Pain-like facial expressions
  • Long crying bouts
  • Evening clustering

Both conditions resolve by 3-4 months of age and affect otherwise healthy infants. 2, 3

Management Approach (Identical for Both)

First-Line: Parental Education and Reassurance

The cornerstone of management is educating parents that this is a benign, self-limiting developmental phase, not a disease requiring cure. 1, 2 The Period of PURPLE Crying program specifically improves mothers' knowledge about crying patterns and behavioral responses, though it has not yet demonstrated strong evidence for preventing abusive head trauma. 1

Evidence-Based Treatment Options

For breastfed infants with colic/PURPLE crying:

  • Lactobacillus reuteri DSM 17938 is the only intervention with strong evidence, reducing crying time by a median of 65 minutes per day. 4, 2
  • Dosing: 5 drops daily for 21 days minimum. 5
  • Clinical response (≥50% reduction in crying) occurs in 85% of infants. 5
  • Maternal dietary allergen elimination (particularly cow's milk protein) may be considered as a second-line option. 2

For formula-fed infants:

  • Switch to extensively hydrolyzed formula if cow's milk protein intolerance is suspected. 2, 3
  • L. reuteri DSM 17938 has less robust evidence in formula-fed infants compared to breastfed infants. 4

Ineffective or Contraindicated Treatments

Avoid these interventions regardless of terminology used:

  • Simethicone—ineffective. 2
  • Proton pump inhibitors—ineffective and not indicated without GI symptoms. 2
  • Dicyclomine—contraindicated due to safety concerns. 2
  • Chiropractic manipulation, infant massage, swaddling, acupuncture, or herbal supplements—lack evidence. 2

Critical Clinical Pitfalls

Rule out organic causes before diagnosing colic/PURPLE crying (occurs in <5% of cases): 6

  • Obtain detailed history focusing on feeding patterns, stool characteristics, and growth parameters
  • Perform thorough physical examination looking for fever, poor weight gain, vomiting, bloody stools, or neurological abnormalities
  • These "red flags" indicate need for further workup rather than reassurance alone. 2, 7

Address maternal mental health: Excessive infant crying significantly increases maternal depression risk. 5 L. reuteri treatment reduced maternal depression scores by 63% at study end, likely through reducing infant crying time. 5

Practical Implementation

Week 1-3: Provide parental education using PURPLE crying framework, initiate L. reuteri DSM 17938 if breastfed, consider hydrolyzed formula if formula-fed. 4, 2

Week 4: Reassess crying duration and parental coping. If no improvement with L. reuteri in breastfed infants, consider maternal elimination diet. 2

Ongoing: Monitor for parental exhaustion and depression, as these are the primary morbidities associated with this condition. 1, 5 The crying itself causes no harm to the infant but creates significant family stress. 6, 3

By 3-4 months: Symptoms should resolve spontaneously regardless of intervention. 2, 3 Persistence beyond this age warrants reevaluation for alternative diagnoses. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Infantile Colic: Recognition and Treatment.

American family physician, 2015

Research

Infantile colic: a review.

The journal of the Royal Society for the Promotion of Health, 2004

Guideline

Efficacy of Lactobacillus reuteri Oral Probiotics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Infant colic: mechanisms and management.

Nature reviews. Gastroenterology & hepatology, 2018

Related Questions

What is the best treatment for a 2-month-old infant with frequent episodes of excessive crying, leg raising, and passing gas?
What is the most appropriate management for a 2‑month‑old infant with normal growth and feeding who has frequent prolonged crying episodes with leg flexion and gas passage?
In a healthy, well‑fed 2‑month‑old infant with normal growth who has frequent, prolonged episodes of intense crying lasting about three hours, during which he lifts his legs and passes gas, what is the most appropriate initial management?
When should parents be concerned about a 5-month-old infant with persistent infantile colic, characterized by nightly crying episodes lasting 30 minutes to 2 hours, sometimes with high-pitched cries?
What is the likely diagnosis and treatment for a 10-month-old baby presenting with increased irritability, crying while holding the back of their head, and white patches over the peri-oral region, without fever or upper respiratory tract infection (URTI) symptoms?
How long should low molecular weight heparin (LMWH) be administered to pregnant women with deep vein thrombosis (DVT)?
What is the recommended dosage of Aceclofenac (nonsteroidal anti-inflammatory drug (NSAID)) for pediatric patients?
What is the management of acute pancreatitis?
What is the role of Atorvastatin (atorvastatin) in managing patients with End-Stage Renal Disease (ESRD) who have experienced an Acute Coronary Syndrome (ACS) with Non-ST-Elevation Myocardial Infarction (NSTEMI)?
Is C-Reactive Protein (CRP) elevated in appendicitis?
What is the management approach for a patient with a high Ranson score indicating severe acute pancreatitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.